lisofylline has been researched along with Lung Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, E; Bursten, S; Fantuzzi, G; George, CL; Leer, L | 1 |
| Lynch, RE | 1 |
1 trial(s) available for lisofylline and Lung Diseases
| Article | Year |
|---|---|
Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Fatty Acids, Nonesterified; Humans; Infusions, Intravenous; Lung Diseases; Pentoxifylline; Prospective Studies; Respiratory Distress Syndrome | 2002 |
2 other study(ies) available for lisofylline and Lung Diseases
| Article | Year |
|---|---|
Effects of lisofylline on hyperoxia-induced lung injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP Response Element-Binding Protein; Fatty Acids; Gene Expression; Hyperoxia; Interleukin-1; Interleukin-6; Lung; Lung Diseases; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Organ Size; Oxidation-Reduction; Pentoxifylline; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |
Lisofylline: anti-acute respiratory distress syndrome or just anti-inflammatory?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Lung Diseases; Pentoxifylline; Respiratory Distress Syndrome | 2002 |